Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2026-03-31 Regulatory Filings
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Sprawozdanie niezależnego biegłego rewidenta z badania (Selvita SA) xhtml
Regulatory Filings
2026-03-31 Polish
Sprawozdanie niezależnego biegłego rewidenta z badania (Selvita SA) pdf
Audit Report / Information Classification · 98% confidence The document is the independent auditor’s report (‘sprawozdanie niezależnego biegłego rewidenta’) on the annual financial statements of Selvita S.A. for the year ended December 31, 2025, including the auditor’s opinion, basis of opinion, key audit matters, and auditor responsibilities. This is a standalone audit report rather than a full annual report or mere announcement. Therefore, it matches the definition of Audit Report / Information. FY 2025
2026-03-31 Polish
Ocena Rady Nadzorczej Selvita S.A. dotycząca sprawozdań Zarządu z działalności oraz sprawozdań finansowych Selvita S.A. i Grupy Kapitałowej Selvita
Regulatory Filings Classification · 90% confidence The document is a formal statement by the Supervisory Board of Selvita S.A. under Polish Ministry of Finance regulations, evaluating the Management Board’s reports on operations and the standalone and consolidated financial statements for 2025. It is not the full annual report itself (10-K), nor an earnings release, audit report, or management narrative. It does not announce a meeting result or capital change. It is a periodic compliance filing under current information rules and therefore falls into the general regulatory/fallback category.
2026-03-31 Polish
Oświadczenie Rady Nadzorczej Selvita S.A. dotyczące funkcjonowania Komitetu Audytu oraz firmy audytorskiej w Selvita S.A. oraz Grupie Kapitałowej Selvita
Governance Information Classification · 80% confidence The document is a statutory statement by the Supervisory Board on the functioning of the Audit Committee and auditor policies, detailing compliance with governance rules (independence criteria, rotation, auditor selection policy). It is not the full annual report, nor the audit report itself, but rather a governance disclosure regarding internal controls and audit oversight. This fits the “Governance Information” category.
2026-03-31 Polish
Jednostkowe sprawozdanie finansowe roczne xhtml.xades
Regulatory Filings
2026-03-31 Polish
Jednostkowe sprawozdanie finansowe roczne xhtml
Regulatory Filings
2026-03-31 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.